In sarcopenia, the downregulation of SLC38A1 leads to inadequate amino acid supply to muscle cells, inhibiting protein synthesis and causing metabolic disorders, which may exacerbate pancreatic cell damage and inflammation after the onset of acute pancreatitis. The gene discussed is SLC38A1; the disease is metabolic disease.